Physiotherapy Equipment Market Forecast, Trends To 2022: Grand View Research, Inc.

Physiotherapy Equipment Market Worth $24.7 Billion By2022Global physiotherapy equipment market size is expected to reach USD 24.7 billion by 2022,according to a new study by Grand View Research Inc. Growing prevalence of neurological andmusculoskeletal disorders are expected to drive the physiotherapy equipment market over theforecast period. The presence of efficient and effective therapies such as ultrasound andcryotherapy, advancement in the technologies coupled with implementation of favorablegovernment policies is expected to significantly contribute towards expedited market growth. In2014, musculoskeletal was the largest application segment with revenue estimated at over USD8.0 billion. However, neurology is expected to witness rapid growth owing to the growingprevalence of Parkinson’s disease, epilepsy and autism in the U.S. and China.View summary of this report @ http://www.grandviewresearch.com/industryanalysis/physiotherapy-equipment-market

3.6 Physiotherapy equipment PESTEL Analysis3.7 Physiotherapy equipment company market share analysis, 2014Chapter 4 Physiotherapy Equipment Types Outlook4.1 Physiotherapy equipment revenue share, by type, 2014 & 20224.2 Hydrotherapy market4.2.1 Hydrotherapy market, 2012 - 2022 (USD Million)4.3 Cryotherapy market4.3.1 Cryotherapy market, 2012 - 2022 (USD Million)4.4 Continuous passive motion (CPM) market4.4.1 CPM market, 2012 - 2022 (USD Million)4.5 Therapeutic exercises market4.5.1 Therapeutic exercises market, 2012 - 2022 (USD Million)4.6 Ultrasound market4.6.1 Ultra sound market, 2012 - 2022 (USD Million)4.7 Electric stimulation market4.7.1 Electric stimulation market, 2012 - 2022 (USD Million)4.8 Heat therapy market4.8.1 Heat therapy market, 2012 - 2022 (USD Million)4.9 Others market4.9.1 Others market, 2012 - 2022 (USD Million)Chapter 5 Physiotherapy Equipment Demographic Outlook5.1 Physiotherapy equipment revenue share, by demographics, 2014 & 20225.2 Physiotherapy market for the geriatric population5.2.1 In-patient treatment market for the geriatric population, 2012 - 2022 (USDmillion)5.2.2 Out-patient treatment market for the geriatric population, 2012 - 2022 (USDmillion)5.2.2.1 Out-patient convalescent homes based treatment market5.2.2.2 Out-patient home based treatment market5.2.2.3 Other out-patient facilities5.3 Non-geriatric population physiotherapy market5.3.1 In-patient treatment market for the non-geriatric population, 2012 - 2022 (USDmillion)5.3.2 Out-patient treatment market for the non-geriatric population, 2012 - 2022(USD million)5.3.2.1 Out-patient convalescent homes based treatment market5.3.2.2 Out-patient home based treatment market5.3.2.3 Other out-patient facilities marketChapter 6 Physiotherapy Equipment End-use Outlook6.1 Physiotherapy equipment revenue share, by end-use, 2014 & 20226.2 Hospitals market6.2.1 Hospitals market, 2012 - 2022 (USD Million)6.3 Clinics market

6.3.1 Clinics market, 2012 - 2022 (USD Million)6.4 Other facilities market6.4.1 Other facilities market, 2012 - 2022 (USD Million)Chapter 7 Physiotherapy Equipment Application Outlook7.1 Physiotherapy equipment revenue share, by application, 2014 & 20227.2 Neurology market7.2.1 Neurology market, 2012 - 2022 (USD Million)7.2.1.1 Stroke7.2.1.1.1 Strokes market, 2012 - 2022 (USD Million)7.2.1.2 Spinal cord injuries7.2.1.2.1 Spinal cord injuries market, 2012 - 2022 (USD Million)7.2.1.3 Parkinson’s disease7.2.1.3.1 Parkinson’s disease market, 2012 - 2022 (USD Million)7.2.1.4 Multiple sclerosis7.2.1.4.1 Multiple sclerosis market, 2012 - 2022 (USD Million)7.2.1.5 Cerebral palsy7.2.1.5.1 Cerebral palsy market, 2012 - 2022 (USD Million)7.2.1.6 Others7.2.1.6.1 Others market, 2012 - 2022 (USD Million)7.3 Musculoskeletal7.3.1 Musculoskeletal market, 2012 - 2022 (USD Million)7.4 Pediatric7.4.1 Pediatric market, 2012 - 2022 (USD Million)7.5 Cardiovascular & Pulmonary7.5.1 Cardiovascular & Pulmonary market, 2012 - 2022 (USD Million)7.6 Others7.6.1 Others market, 2012 - 2022 (USD Million)Chapter 8 Physiotherapy Equipment Regional Outlook8.1 Physiotherapy equipment revenue share, by region, 2014 & 20228.2 North America physiotherapy equipment market8.2.1 North America physiotherapy equipment market, 2012 - 2022 (USD Million)8.2.1.1 U.S. physiotherapy equipment market8.2.1.1.1 U.S. physiotherapy equipment market, 2012 - 2022 (USDMillion)8.2.1.2 Canada physiotherapy equipment market8.2.1.2.1 Canada physiotherapy equipment market, 2012 - 2022 (USDMillion)8.3 Europe physiotherapy equipment market8.3.1 Europe physiotherapy equipment market, 2012 - 2022 (USD Million)8.3.1.1 U.K. physiotherapy equipment market8.3.1.1.1 U.K. physiotherapy equipment market, 2012 - 2022 (USDMillion)8.3.1.2 Germany physiotherapy equipment market

Million)Million)Million)Million)Million)Million)8.3.1.2.1 Germany physiotherapy equipment market, 2012 - 2022 (USD8.3.1.3 France physiotherapy equipment market8.3.1.3.1 France physiotherapy equipment market, 2012 - 2022 (USD8.4 Asia Pacific physiotherapy equipment market8.4.1 Asia Pacific physiotherapy equipment market, 2012 - 2022 (USD Million)8.4.1.1 Japan physiotherapy equipment market8.4.1.1.1 Japan physiotherapy equipment market, 2012 - 2022 (USD8.4.1.2 China physiotherapy equipment market8.4.1.2.1 China physiotherapy equipment market, 2012 - 2022 (USD8.4.1.3 India physiotherapy equipment market8.4.1.3.1 India physiotherapy equipment market, 2012 - 2022 (USD8.5 Latin America physiotherapy equipment market8.5.1 Latin America physiotherapy equipment market, 2012 - 2022 (USD Million)8.5.1.1 Brazil physiotherapy equipment market8.5.1.1.1 Brazil physiotherapy equipment market, 2012 - 2022 (USD8.5.1.2 Mexico physiotherapy equipment market8.5.1.2.1 Mexico physiotherapy equipment market, 2012 - 2022 (USDMillion)8.6 MEA physiotherapy equipment market8.6.1 MEA physiotherapy equipment market, 2012 - 2022 (USD Million)8.6.1.1 South Africa physiotherapy equipment market8.6.1.1.1 South Africa Physiotherapy Equipment market, 2012 - 2022(USD Million)Chapter 9 Competitive Landscape9.1 Patterson Medical9.1.1 Company overview9.1.2 Financial performance9.1.3 Product benchmarking9.1.4 Strategic initiatives9.2 DJO Global9.2.1 Company overview9.2.2 Financial performance9.2.3 Product benchmarking9.2.4 Strategic initiatives9.3 Enraf-Nonius9.3.1 Company overview9.3.2 Financial performance

9.3.3 Product benchmarking9.3.4 Strategic initiatives9.4 BTL Industries9.4.1 Company overview9.4.2 Financial performance9.4.3 Product benchmarking9.4.4 Strategic initiatives9.5 EMS Physio9.5.1 Company overview9.5.2 Financial performance9.5.3 Product benchmarking9.5.4 Strategic initiatives9.6 Isokinetic Inc.9.6.1 Company overview9.6.2 Financial performance9.6.3 Product benchmarking9.6.4 Strategic initiativesBrowse full report @ http://www.grandviewresearch.com/industry-analysis/physiotherapyequipment-marketList of TablesTABLE 1 Physiotherapy Equipment Market - Industry Snapshot & Key Buying Criteria, 2012 -2022TABLE 2 Global physiotherapy equipment market, by application, 2012 - 2022 (USD Million)TABLE 3 Global physiotherapy equipment market, by end-use, 2012 - 2022 (USD Million)TABLE 4 Global physiotherapy equipment market, by type, 2012 - 2022 (USD Million)TABLE 5 Global physiotherapy equipment market, by region, 2012 - 2022 (USD Million)TABLE 6 Physiotherapy equipment - Key market driver analysisTABLE 7 Physiotherapy equipment - Key market restraint analysisTABLE 8 North America market, by country, 2012 - 2022 (USD Million)TABLE 9 North America market, by application, 2012 - 2022 (USD Million)TABLE 10 North America market, by neurology, 2012 - 2022 (USD Million)TABLE 11 North America market, by types, 2012 - 2022 (USD Million)TABLE 12 North America market, by demographic, 2012 - 2022 (USD Million)TABLE 13 North America market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 14 North America market, by geriatric out-patient population, 2012 - 2022 (USDMillion)

TABLE 15 North America market, by non-geriatric population treatment, 2012 - 2022 (USDMillion)TABLE 16 North America market, by non-geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 17 North America market, by end-use, 2012 - 2022 (USD Million)TABLE 18 U.S. market, by application, 2012 - 2022 (USD Million)TABLE 19 U.S. market, by neurology, 2012 - 2022 (USD Million)TABLE 20 U.S. market, by types, 2012 - 2022 (USD Million)TABLE 21 U.S. market, by demographic, 2012 - 2022 (USD Million)TABLE 22 U.S. market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 23 U.S. market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 24 U.S. market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 25 U.S. market, by non-geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 26 U.S. market, by end-use, 2012 - 2022 (USD Million)TABLE 27 Canada market, by application, 2012 - 2022 (USD Million)TABLE 28 Canada market, by neurology, 2012 - 2022 (USD Million)TABLE 29 Canada market, by types, 2012 - 2022 (USD Million)TABLE 30 Canada market, by demographic, 2012 - 2022 (USD Million)TABLE 31 Canada market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 32 Canada market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 33 Canada market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 34 Canada market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 35 Canada market, by end-use, 2012 - 2022 (USD Million)TABLE 36 Europe market, by country, 2012 - 2022 (USD Million)TABLE 37 Europe market, by application, 2012 - 2022 (USD Million)TABLE 38 Europe market, by neurology, 2012 - 2022 (USD Million)TABLE 39 Europe market, by types, 2012 - 2022 (USD Million)TABLE 40 Europe market, by demographic, 2012 - 2022 (USD Million)TABLE 41 Europe market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 42 Europe market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 43 Europe market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 44 Europe market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 45 Europe market, by end-use, 2012 - 2022 (USD Million)TABLE 46 UK market, by application, 2012 - 2022 (USD Million)TABLE 47 UK market, by neurology, 2012 - 2022 (USD Million)TABLE 48 UK market, by types, 2012 - 2022 (USD Million)TABLE 49 UK market, by demographic, 2012 - 2022 (USD Million)TABLE 50 UK market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 51 UK market, by geriatric out-patient population treatment, 2012 - 2022 (USD Million)

TABLE 52 UK market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 53 UK market, by non-geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 54 UK market, by end-use, 2012 - 2022 (USD Million)TABLE 55 Germany market, by application, 2012 - 2022 (USD Million)TABLE 56 Germany market, by neurology, 2012 - 2022 (USD Million)TABLE 57 Germany market, by types, 2012 - 2022 (USD Million)TABLE 58 Germany market, by demographic, 2012 - 2022 (USD Million)TABLE 59 Germany market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 60 Germany market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 61 Germany market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 62 Germany market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 63 Germany market, by end-use, 2012 - 2022 (USD Million)TABLE 64 France market, by application, 2012 - 2022 (USD Million)TABLE 65 France market, by neurology, 2012 - 2022 (USD Million)TABLE 66 France market, by types, 2012 - 2022 (USD Million)TABLE 67 France market, by demographic, 2012 - 2022 (USD Million)TABLE 68 France market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 69 France market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 70 France market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 71 France market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 72 France market, by end-use, 2012 - 2022 (USD Million)TABLE 73 Asia Pacific market, by country, 2012 - 2022 (USD Million)TABLE 74 Asia Pacific market, by application, 2012 - 2022 (USD Million)TABLE 75 Asia Pacific market, by neurology, 2012 - 2022 (USD Million)TABLE 76 Asia Pacific market, by types, 2012 - 2022 (USD Million)TABLE 77 Asia Pacific market, by demographic, 2012 - 2022 (USD Million)TABLE 78 Asia Pacific market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 79 Asia Pacific market, by geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 80 Asia Pacific market, by non-geriatric population treatment, 2012 - 2022 (USDMillion)TABLE 81 Asia Pacific market, by non-geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 82 Asia Pacific market, by end-use, 2012 - 2022 (USD Million)TABLE 83 Japan market, by application, 2012 - 2022 (USD Million)TABLE 84 Japan market, by neurology, 2012 - 2022 (USD Million)TABLE 85 Japan market, by types, 2012 - 2022 (USD Million)TABLE 86 Japan market, by demographic, 2012 - 2022 (USD Million)TABLE 87 Japan market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 88 Japan market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)

TABLE 89 Japan market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 90 Japan market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 91 Japan market, by end-use, 2012 - 2022 (USD Million)TABLE 92 China market, by application, 2012 - 2022 (USD Million)TABLE 93 China market, by neurology, 2012 - 2022 (USD Million)TABLE 94 China market, by types, 2012 - 2022 (USD Million)TABLE 95 China market, by demographic, 2012 - 2022 (USD Million)TABLE 96 China market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 97 China market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 98 China market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 99 China market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 100 China market, by end-use, 2012 - 2022 (USD Million)TABLE 101 India market, by application, 2012 - 2022 (USD Million)TABLE 102 India market, by neurology, 2012 - 2022 (USD Million)TABLE 103 India market, by types, 2012 - 2022 (USD Million)TABLE 104 India market, by demographic, 2012 - 2022 (USD Million)TABLE 105 India market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 106 India market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 107 India market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 108 India market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 109 India market, by end-use, 2012 - 2022 (USD Million)TABLE 110 Latin America market, by country, 2012 - 2022 (USD Million)TABLE 111 Latin America market, by application, 2012 - 2022 (USD Million)TABLE 112 Latin America market, by neurology, 2012 - 2022 (USD Million)TABLE 113 Latin America market, by types, 2012 - 2022 (USD Million)TABLE 114 Latin America market, by demographic, 2012 - 2022 (USD Million)TABLE 115 Latin America market, by geriatric population treatment, 2012 - 2022 (USDMillion)TABLE 116 Latin America market, by geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 117 Latin America market, by non-geriatric population treatment, 2012 - 2022 (USDMillion)TABLE 118 Latin America market, by non-geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 119 Latin America market, by end-use, 2012 - 2022 (USD Million)TABLE 120 Brazil market, by application, 2012 - 2022 (USD Million)TABLE 121 Brazil market, by neurology, 2012 - 2022 (USD Million)TABLE 122 Brazil market, by types, 2012 - 2022 (USD Million)TABLE 123 Brazil market, by demographic, 2012 - 2022 (USD Million)TABLE 124 Brazil market, by geriatric population treatment, 2012 - 2022 (USD Million)

TABLE 125 Brazil market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 126 Brazil market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 127 Brazil market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 128 Brazil market, by end-use, 2012 - 2022 (USD Million)TABLE 129 Mexico market, by application, 2012 - 2022 (USD Million)TABLE 130 Mexico market, by neurology, 2012 - 2022 (USD Million)TABLE 131 Mexico market, by types, 2012 - 2022 (USD Million)TABLE 132 Mexico market, by demographic, 2012 - 2022 (USD Million)TABLE 133 Mexico market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 134 Mexico market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 135 Mexico market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 136 Mexico market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 137 Mexico market, by end-use, 2012 - 2022 (USD Million)TABLE 138 MEA market, by country, 2012 - 2022 (USD Million)TABLE 139 MEA market, by application, 2012 - 2022 (USD Million)TABLE 140 MEA market, by neurology, 2012 - 2022 (USD Million)TABLE 141 MEA market, by types, 2012 - 2022 (USD Million)TABLE 142 MEA market, by demographic, 2012 - 2022 (USD Million)TABLE 143 MEA market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 144 MEA market, by geriatric out-patient population treatment, 2012 - 2022 (USDMillion)TABLE 145 MEA market, by non-geriatric population treatment, 2012 - 2022 (USD Million)TABLE 146 MEA market, by non-geriatric out-patient population, 2012 - 2022 (USD Million)TABLE 147 MEA market, by end-use, 2012 - 2022 (USD Million)TABLE 148 South Africa market, by application, 2012 - 2022 (USD Million)TABLE 149 South Africa market, by neurology, 2012 - 2022 (USD Million)TABLE 150 South Africa market, by types, 2012 - 2022 (USD Million)TABLE 151 South Africa market, by demographic, 2012 - 2022 (USD Million)TABLE 152 South Africa market, by geriatric population treatment, 2012 - 2022 (USD Million)TABLE 153 South Africa market, by geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 154 South Africa market, by non-geriatric population treatment, 2012 - 2022 (USDMillion)TABLE 155 South Africa market, by non-geriatric out-patient population, 2012 - 2022 (USDMillion)TABLE 156 South Africa market, by end-use, 2012 - 2022 (USD Million)For More Information visit http://www.grandviewresearch.com/industryanalysis/physiotherapy-equipment-market

List Of FiguresFIG. 1 Physiotherapy equipment market segmentationFIG. 2 Global physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 3 Physiotherapy equipment market dynamicsFIG. 4 Rising geriatric population, by geography, 2013 & 2035 (% increase)FIG. 5 Premature death rate in UK due to unhealthy lifestyleFIG. 6 Key Opportunities PrioritizedFIG. 7 Physiotherapy equipment market Porter’s analysisFIG. 8 Physiotherapy equipment market PESTEL analysisFIG. 9 Physiotherapy equipment revenue, share by type, 2014 & 2022FIG. 10 Hydrotherapy market, 2012 - 2022 (USD Million)FIG. 11 Cryotherapy market, 2012 - 2022 (USD Million)FIG. 12 CPM market, 2012 - 2022 (USD Million)FIG. 13 Therapeutic exercises market, 2012 - 2022 (USD Million)FIG. 14 Ultrasound market, 2012 - 2022 (USD Million)FIG. 15 Electric stimulation market, 2012 - 2022 (USD Million)FIG. 16 Heat therapy market, 2012 - 2022 (USD Million)FIG. 17 Others market, 2012 - 2022 (USD Million)FIG. 18 Physiotherapy equipment revenue share by demographics, 2014 & 2022FIG. 19 In-patient treatment market for the geriatric population, 2012 - 2022 (USD million)FIG. 20 Out-patient treatment market, 2012 - 2022 (USD Million)FIG. 21 Out-patient convalescent homes based treatment market, 2012 - 2022 (USD Million)FIG. 22 Out-patient home based treatment market, 2012 - 2022 (USD Million)FIG. 23 Other out-patient facilities market, 2012 - 2022 (USD Million)FIG. 24 In-patient treatment market for the non-geriatric population, 2012 - 2022 (USD Million)FIG. 25 Out-patient treatment market for the non-geriatric population, 2012 - 2022 (USDMillion)FIG. 26 Out-patient convalescent homes based treatment market, 2012 - 2022 (USD Million)FIG. 27 Out-patient home based treatment market, 2012 - 2022 (USD Million)FIG. 28 Other out-patient facilities market, 2012 - 2022 (USD Million)FIG. 29 Physiotherapy equipment revenue share, by end-use, 2014 & 2022FIG. 30 Hospitals market, 2012 - 2022 (USD Million)FIG. 31 Clinics market, 2012 - 2022 (USD Million)FIG. 32 Other facilities market, 2012 - 2022 (USD Million)FIG. 33 Physiotherapy equipment revenue share by region, 2014 & 2022FIG. 34 North America physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 35 U.S. physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 36 Canada physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 37 Europe physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 38 UK physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 39 Germany physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 40 France physiotherapy equipment market, 2012 - 2022 (USD Million)

FIG. 41 Asia Pacific physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 42 Japan physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 43 China physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 44 India physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 45 Latin America physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 46 Brazil physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 47 Mexico physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 48 MEA physiotherapy equipment market, 2012 - 2022 (USD Million)FIG. 49 South Africa physiotherapy equipment market, 2012 - 2022 (USD Million)Further key findings from the study suggest:Ultrasound was the largest physiotherapy segment of the market in 2014 and is expectedto witness a lucrative growth of over 8.0% over the forecast period. The fact that it is themost common therapy for the management of soft tissue lesions which constitutes one ofthe causes for rheumatic complaints and renders reduction in the healing time of softtissue injuries is expected to drive growth.Hospitals dominated the end-use market owing to, presence of high patient volume andthe supportive infrastructure. On the other hand, the home based treatment is expected tospearhead the growth of the other facilities segment during the forecast period. Costeffectiveness associated with this treatment facility is likely to drive segment growth. North America dominated the market in 2014, with revenue estimated at USD 5.74billion. Increasing baby boomer population, presence of favorable government policiesand sophisticated healthcare infrastructure are some key drivers of this market.Asia Pacific is expected to witness substantial growth during the forecast period owing torising population, high investment opportunities and developing healthcare infrastructure.Japan was the largest Asia Pacific market in 2014. By 2025, Japan is anticipated to haveover 36% of its population over the age of 60 along with being one of the largesteconomies in terms of healthcare providers. Health insurance coverage for physiotherapytreatments and services is expected to spur market expansion. According to the JapaneseNational Health Insurance, over 90% of the cost for homecare services and devices isreimbursed promoting higher spending by patients.Key players of the physiotherapy equipment market include DJO Global, PattersonMedical, Isokinetics Inc., EMS Physio and BTL Industries.Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/physiotherapy-equipment-market/request

For the purpose of this study, Grand View Research has segmented the physiotherapy equipmentmarket on the basis of products:Global Physiotherapy Equipment Application Outlook (Revenue, USD Million) 2012 –2022)Neurology Stroke Spinal cord injuries Parkinson’s disease Multiple sclerosis Cerebral palsy Others Musculoskeletal Pediatric Cardiovascular & Pulmonary OthersGlobal Physiotherapy Equipments Types Outlook (Revenue, USD Million, 2012 – 2022)HydrotherapyCryotherapyCPMUltrasoundElectric StimulationHeat TherapyTherapeutic ExerciseOthersGlobal Physiotherapy Equipments Demographic Outlook (Revenue, USD Million) 2012 –2022)Geriatric population In-patient (hospital) treatment Out-patient treatment• Convalescent homes based treatment• Home based treatment• OthersNon-geriatric population In-patient (hospital) treatment Out-patient treatment• Convalescent homes based treatment• Home based treatment• Others

Global Physiotherapy Equipment End Use Outlook (Revenue, USD Million) 2012 – 2022)HospitalsClinicsOthersPhysiotherapy Equipment Regional Outlook (Revenue, USD Million) 2012 – 2022)North America U.S. CanadaEurope UK Germany France Rest of EuropeAsia Pacific Japan China India Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin AmericaMiddle East and Africa South AfricaRest of Middle East and AfricaBrowse All Reports of this category @http://www.grandviewresearch.com/industry/medical-devicesAbout Grand View ResearchGrand View Research, Inc. is a market research and consulting company that provides off-theshelf,customized research reports and consulting services. To help clients make informedbusiness decisions, we offer market intelligence studies ensuring relevant and fact-based researchacross a range of industries, from technology to chemicals, materials and energy. With a deepseatedunderstanding of varied business environments, Grand View Research provides strategicobjective insights.

Contact:Sherry JamesCorporate Sales Specialist, U.S.A.Grand View Research, Inc.United StatesPhone: 1-415-349-0058Toll Free: 1-888-202-9519Email: sales@grandviewresearch.comWebsite: Grand View ResearchBlog Site: http://www.divog.org/